Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
72.45
+0.30 (0.42%)
Sep 9, 2025, 4:00 PM - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $1.19 billion as of September 10, 2025. Its market cap has increased by 591.02% in one year.
Market Cap
1.19B
Enterprise Value
5.79B
1-Year Change
591.02%
Ranking
Category
Stock Price
$72.45
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $1.19B, an increase of 391.19%. That is a compound annual growth rate of 34.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1.19B | 397.33% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |